Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech, Inc. (NASDAQ: SNES) generates news as a biotechnology company focused on fertility control for rodent management. Its announcements frequently highlight developments related to ContraPest®, Evolve Rat, and Evolve Mouse Birth Control, which are described as contraceptive products for rats and mice that fit into integrated pest management programs and reduce reliance on traditional rodenticides.
Investors and observers following SNES news will see regular updates on financial performance and growth in Evolve rodent birth control products. Quarterly press releases report record revenues, gross profit margins, and the share of revenue contributed by Evolve-branded products, as well as commentary on adjusted EBITDA and cash balances. These releases often discuss progress toward profitability and the impact of multi-channel distribution strategies.
Company news also covers operational and commercial milestones. Examples include the launch of Evolve Rat Birth Control on major e-commerce platforms and home improvement retailer websites, expanded retail coverage through partners and wholesalers, and municipal pilot deployments in U.S. cities. Additional updates describe international distribution relationships, such as the appointment of the Belize Raptor Center as an official distributor following regulatory approval in Belize.
Regulatory and capital markets activities appear in SenesTech’s news flow as well. The company issues press releases on warrant exercises, gross proceeds from financings, and participation in investor conferences. For readers tracking SNES, this news page offers a way to monitor how SenesTech reports on product adoption, distribution channels, municipal and community programs, and financing events over time.
SenesTech (Nasdaq: SNES) will directly manage Amazon sales of its Evolve Rat and Evolve Mouse products effective immediately, shifting from third-party sellers to in‑house e-commerce operations.
In 2025, e-commerce accounted for over 50% of revenue, with roughly half already company-managed. The change aims to increase revenue retention, improve margins, and enhance customer messaging and performance data access, with financial benefits expected to begin in Q1 and strengthen in Q2.
SenesTech (Nasdaq: SNES) announced that its fertility control product Evolve received approval for use in New Zealand from the Ministry for Primary Industries and that its exclusive distributor Evicom has received an initial stocking shipment.
Evolve is positioned as a non‑lethal, environmentally focused rodent control tool aligned with New Zealand's Predator Free 2050 initiative and the country's planned $4.5 billion investment in eradication technology.
SenesTech (NASDAQ: SNES) announced that President and CEO Joel Fruendt plans to retire and will remain in his role until a successor is found or June 30, 2026. The Board will launch a formal search and has appointed Dr. Jamie Bechtel as Interim Executive Chair to support strategic alignment and continuity during the transition.
The company said interim COO Michael Edell and CFO Tom Chesterman will continue day-to-day operations while an executive search firm assists the Board.
SenesTech (NASDAQ: SNES) announced on Nov 11, 2025 that the Belize Raptor Center, led by Sarah Mann, is an official international distributor of Evolve Rat Birth Control after receiving import and distribution approval from the Pesticides Control Board of Belize. The move aims to offer a non‑lethal, fertility‑based alternative to toxic rodenticides to protect Belize's biodiversity and reduce secondary wildlife poisonings.
The distributor partnership includes a grassroots education campaign for citizens, businesses, and officials to promote integrated pest management and phase out harmful anticoagulant and neurotoxic rodenticides.
SenesTech (NASDAQ: SNES) reported Q3 2025 results with record revenue of $690,000, a 43% increase versus Q3 2024, driven by 77% YoY growth in Evolve Rodent Birth Control products, which now represent 85% of total revenue. Gross margin was 62.8%. Net loss narrowed to $1.3M from $1.5M, and Adjusted EBITDA loss improved to $1.2M, both company records. Cash and short-term investments totaled $10.2M, supporting the company's runway and pursuit of breakeven. Key channel growth: e-commerce +55% YoY, municipal +139% YoY, retail +254% YoY, and pest management +29% YoY (≈20% of revenue).
The company highlighted multi-channel distribution traction, one-time Q3 legal and lease costs, and a webcast conference call on Nov 10, 2025.
SenesTech (NASDAQ: SNES) announced that its Evolve® Rat Birth Control® is now available online at Lowes.com as of Nov. 10, 2025. This e-commerce launch gives Evolve Rat access to millions of homeowners via one of the nation's largest home improvement retailers.
Company notes Lowes has over 1,700 stores and $11 billion in online sales, growing at nearly 10% per year. The product is described as a non‑poison, soft bait that reduces rat reproduction and is positioned for potential in‑store expansion if online demand supports retail rollout.
SenesTech (NASDAQ: SNES) will report third quarter 2025 financial results for the period ended September 30, 2025 after the market close on Monday, November 10, 2025.
The company will host a conference call the same day at 5:00 p.m. Eastern time to review results. Interested parties can access the live webcast via the Investor Relations section of the company website at https://app.webinar.net/Pj7rLgb3Ew4 or http://senestech.investorroom.com/. A webcast replay will be available on the Investor Relations site for 90 days.
SenesTech (NASDAQ: SNES) announced the Town of Swampscott launched a pilot deploying Evolve® Rat Birth Control at the Swampscott Firehouse and a local school beginning Oct. 13, 2025.
The humane fertility control bait targets rat reproduction rather than using traditional poisons and is described as palatable to rats and safe for non-target species. The pilot runs through the fall with monitoring by city officials, product specialists, Speak Up for Animals, and local advocates; expansion to more neighborhoods in 2026 is possible if results are successful.
SenesTech (NASDAQ: SNES), a leader in fertility control solutions for animal pest populations, has announced its participation in the upcoming Lytham Partners Fall 2025 Investor Conference on September 30, 2025.
The company will deliver a webcast presentation at 2:45 p.m. ET and conduct one-on-one meetings with investors during the virtual event. Investors can access the webcast through the conference website and schedule individual meetings with management through Lytham Partners.
SenesTech (NASDAQ: SNES) announced that its Evolve™ Rat Birth Control product is now available for purchase on HomeDepot.com, marking a significant expansion in consumer accessibility. The product is the first and only soft bait targeting rat reproduction, offering a non-toxic alternative to traditional pest control methods.
The launch on Home Depot's online platform, which processed over 395 million online transactions in 2024, represents a strategic move to reach millions of homeowners through a major retail channel. The product can be shipped nationwide for store pickup or direct delivery to consumers.
FAQ
What is the current stock price of Senestech (SNES)?
What is the market cap of Senestech (SNES)?
